-
Globus Medical director sells $550K in stock
Globus Medical director Leslie Norwalk sold 10,590 shares of the company's Class A common stock, according to a March 15 SEC filing. -
Spineart secures $22.5M in financing
Spine devicemaker Spineart raised $22.5 million in convertible financing shortly after finishing enrollment for its cervical disc replacement trial. -
Carlsmed developing personalized cervical spinal fusion implants
Spine devicemaker Carlsmed raised $52.5M in series C funding and will use the money to develop patient-specific cervical implants, the company said March 18. -
Orthofix adds new executive leader
Lucas Vitale joined Orthofix as chief people and business operations officer, the company said March 18. -
Bioretec earns breakthrough designation for spinal interbody cage
Bioretec earned the FDA's breakthrough device designation for its RemeOs spinal interbody cage, the company said March 14. -
5 medtech notes: Stryker, Xtant Medical and more
Here are five key updates from spine and orthopedic devicemakers since March 6. -
Apple Vision Pro used in its 1st UK spinal operation
Surgeons at London-based Cromwell Hospital became the first in the country to use tech company Apple's Vision Pro headset during a spinal operation. -
Washington payer adds coverage for lumbar disc implant
The largest commercial payer in Washington implemented coverage for Centinel Spine's Prodisc L implant, the devicemaker said March 12. -
L&K Spine's revolutionary achievement: 1,200 level implantation of PathLoc-TM, PLIF/TLIF Expandable Cage
L&K Spine Inc. proudly announces a groundbreaking milestone in the field of spine surgery: the 1,200th successful implantation of PathLoc-TM, PLIF/TLIF Expandable Cage in US as of January 2024. This achievement marks a significant advancement in spine surgery and underscores our commitment to improving patient outcomes through innovative products. -
Artificial disc replacement to crack $1B by 2030
The artificial disc replacement market is expected to grow at a compound annual growth rate of 12.3% between 2023 and 2030, according to Vantage Market Research. -
Xtant Medical boosts credit facility with MidCap Financial
Xtant Medical had its credit facility with MidCap Financial raised from $8 million to $17 million, according to a March 7 news release. -
3 spine, orthopedic medtech warnings, recalls in 2024
Becker's reported on three product recalls from spine and orthopedic medtech companies so far in 2024. -
Medtronic launches data collection tool for spine
Medtronic launched the UNiD ePro service in the U.S., the company said March 6. -
OrthoPediatrics' revenue grows 22%
OrthoPediatrics has announced a revenue of $148.7 million in 2023, up 22% from the year prior. -
5 medtech notes: Orthofix, ZimVie and more
Here are five key developments from spine devicemakers since Feb. 28. -
Orthofix sees 64% increase in Q4 revenue
Orthofix's fourth quarter sales grew 64%, and its full year revenue rose 62%, according to financial results posted March 5. -
2 spine companies launching public offering
Two spine companies launched public offerings since Feb. 26. -
Alphatec CFO sells 121K shares of stock
Alphatec CFO John Koning sold 121,601 shares of company stock on March 1, according to SEC documents. -
OrthoPediatrics launches new scoliosis treatment system
OrthoPediatrics has launched a new system, the Response rib and pelvic fixation system, to treat children with early onset scoliosis. -
Medtronic named among world's 'most ethical' companies
Orthopedic and spine tech manufacturer Medtronic has been named among the world's most ethical companies by for-profit ethical standards company the Ethisphere Institute.
Page 13 of 201